FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

13667911000001104: Tyverb 250mg tablets (GlaxoSmithKline) 70 tablet 7 x 10 tablets (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
48698001000001118 Tyverb 250mg tablets (GlaxoSmithKline) 70 tablet 7 x 10 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
92804701000001119 Tyverb 250mg tablets (Novartis Pharmaceuticals UK Ltd) 70 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tyverb 250mg tablets (GlaxoSmithKline) 70 tablet 7 x 10 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline) 70 tablet 7 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline) 70 tablet 7 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline) 70 tablet 7 x 10 tablets Is a Lapatinib 250mg tablets 70 tablet true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline) 70 tablet 7 x 10 tablets Is pack of Tyverb 250mg tablets (GlaxoSmithKline) false Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline) 70 tablet 7 x 10 tablets Has active ingredient Lapatinib ditosylate false Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline) 70 tablet 7 x 10 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline) 70 tablet 7 x 10 tablets Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline) 70 tablet 7 x 10 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline) 70 tablet 7 x 10 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline) 70 tablet 7 x 10 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline) 70 tablet 7 x 10 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline) 70 tablet 7 x 10 tablets Has AMP Tyverb 250mg tablets (GlaxoSmithKline) true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline) 70 tablet 7 x 10 tablets Has specific active ingredient Lapatinib ditosylate monohydrate false Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline) 70 tablet 7 x 10 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline) 70 tablet 7 x 10 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline) 70 tablet 7 x 10 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline) 70 tablet 7 x 10 tablets Has specific active ingredient Lapatinib ditosylate monohydrate true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline) 70 tablet 7 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Lapatinib true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start